Analysis of immune responses against a wide range of Mycobacterium tuberculosis antigens in patients with active pulmonary tuberculosis

Clinical and Vaccine Immunology

Volumn 19, Issue 12, 2012, Pages 1907-1915

  Kassa, Desta ^a,b   Ran, Leonie ^b   Geberemeskel, Wudneh ^a   Tebeje, Mekashaw ^a   Alemu, Amelewerk ^a   Selase, Alemayehu ^c   Tegbaru, Belete ^a   Franken, Kees L M C ^d   Friggen, Annemieke H ^d   Van Meijgaarden, Krista E ^d   Ottenhoff, Tom H M ^d   Wolday, Dawit ^e   Messele, Tsehaynesh ^a   Van Baarle, Debbie ^b  

^a ETHIOPIAN PUBLIC HEALTH INSTITUTE   (Ethiopia)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c St Peter Specialized TB Hospital   (Ethiopia)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Medical Biotech Laboratory   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN 85A; ANTIGEN 85B; CULTURE FILTRATE PROTEIN 10; DOSR REGULON ENCODED ANTIGEN; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; HEAT SHOCK PROTEIN 65; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MYCOBACTERIUM ANTIGEN; MYCOBACTERIUM ANTIGEN TB10.4; MYCOBACTERIUM TUBERCULOSIS ANTIGEN; REACTIVATION ASSOCIATED ANTIGEN; RESUSCITATION PROMOTING FACTOR ANTIGEN; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SERODIAGNOSIS; SUPERNATANT;

ADULT; ANTIGENS, BACTERIAL; CELLS, CULTURED; CROSS-SECTIONAL STUDIES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOLOGIC TESTS; LEUKOCYTES, MONONUCLEAR; MALE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 84870469413     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00482-12     Document Type: Article

References (53)

1. Aagaard C, et al. 2006. Optimizing antigen cocktails for detection of Mycobacterium bovis in herds with different prevalence of bovine tuberculosis: ESAT-6-CRP-10 mixture shows optimal sensitivity and specificity. J. Clin. Microbiol. 44:4326-4335. (Pubitemid 44937059)
2. Al-Attiyah RA, Mustafa S, Abal A, El-Shamy M, Dalemans AS, Skeiky YAW. 2004. In vitro cellular immune responses to complex and newly defined recombinant antigens of Mycobacterium tuberculosis. Clin. Exp. Immunol. 138:139-144. (Pubitemid 39279976)
3. American Thoracic Society. 2000. Diagnostic standards and classification of tuberculosis in adults and children. Am. J. Respir. Crit. Care Med. 161:1376-1395.
4. Andersen P. 1994. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 62:2536-2544. (Pubitemid 24157087)
5. Andersen P, Andersen AB, Sorensen AL, Nagai S. 1995. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J. Immunol. 154:3359-3372.
6. Bertholet S, et al. 2008. Reed identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis. J. Immunol. 181:7948-7957.
7. Black GF, et al. 2009. Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa. Clin. Vaccine Immunol. 16:1203-1212.
8. Boesen H, Jensen BN, Wilcke T, Andersen P. 1995. Human T cell responses to secreted antigen fraction of Mycobacterium tuberculosis. Infect. Immun. 63:1491-1497.
9. Boussiotis V, et al. 2000. IL-10 producing T cells suppress immune responses in anergic tuberculosis patients. J. Clin. Invest. 105:1317-1325. (Pubitemid 30266085)
10. Brodin P, et al. 2005. Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity. J. Biol. Chem. 280:33953-33959. (Pubitemid 41443115)
11. Brodin P, Rosenkrands I, Andersen P, Cole ST, Brosch R. 2004. ESAT-6 proteins: protective antigens and virulence factors? Trends Microbiol. 12:500-508. (Pubitemid 39370732)
12. Colditz GA, Brewer TF, Berkey CS. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271:698-702. (Pubitemid 24061706)
13. + T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals. Eur. J. Immunol. 41:2925-2936.
14. Commandeur S, et al. 2011. Identification of human T-cell responses to Mycobacterium tuberculosis resuscitation-promoting factors in long-term latently infected individuals. Clin. Vaccine Immunol. 18:676-683.
15. Day CL, et al. 2011. Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J. Immunol. 187:2222-2232.
16. de Jager W, Velthuis H, Prakken BJWK, Rijkers GT. 2003. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin. Diagn. Lab. Immunol. 10:133-139. (Pubitemid 36133841)
17. Demissie A, et al. 2006. Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis. Clin. Vaccine Immunol. 13:179-186. (Pubitemid 43383784)
18. Federal Ministry of Health. 2005. Manual of tuberculosis, leprosy and TB/HIV prevention and control programme, 3rd ed. Federal Ministry of Health, Addis Ababa, Ethiopia.
19. Feng C, Bean A, Hooi H, Briscoe H, Britton W. 1999. Increase in gamma-interferon secreting CD8+, as well as CD4+ T cells in lungs following aerosol infection with Mycobacterium tuberculosis. Infect. Immun. 67:3242-3247. (Pubitemid 29291487)
20. Franken KL, et al. 2000. Purification of His-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent. Protein Expr. Purif. 18:95-99. (Pubitemid 30097778)
21. Frieden TR, Sterling SS, Munsiff Watt CJ, Dye C. 2003. Tuberculosis. Lancet 362:887-899. (Pubitemid 37130100)
22. Handzel ZT, et al. 2007. Increased Th1 and Th2 type cytokine production in patients with active tuberculosis. IMAJ 9:479-483. (Pubitemid 46979155)
23. Hervas-Stubbs S, et al. 2006. High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection. Infect. Immun. 74:3396-3407. (Pubitemid 43794530)
24. Jabado N, Philippe G. 2005. Tuberculosis: the genetics of vulnerability. Nature 434:709-711. (Pubitemid 40558356)
25. Kaufmann SHE, Parida SK. 2008. Tuberculosis in Africa: learning from pathogenesis for biomarker identification. Cell Host Microbe 4:219-228.
26. Khader SA, Cooper AM. 2008. IL-23 and IL-17 in tuberculosis. Cytokine 41:79-83.
27. Launois P, et al. 1994. T-cell epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect. Immun. 62:3679-3687.
28. Leyten EM, et al. 2006. Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect. 8:2052-2060. (Pubitemid 44311602)
29. Madi NM, Al-Attiyah R, Fahaban Mustafa AS, Atbal Fftung Hgiker Ravn P, Andersen P. 1998. Effective chemotherapy restores T-cell responses to M. tuberculosis antigens in tuberculosis patients, p 439-442. In Talwar GP, Nath I, Ganguly NK, Rao KVS (ed), Proceedings of the 10th International Immunology Congress. Monduzzi Editore, Bologna, Italy.
30. Mattos AM, et al. 2010. Increased IgG1, IFN-{gamma}, TNF-{alpha} and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy. Int. Immunol. 22:775-782.
31. Mukamolova GV, et al. 2002. The rpf gene of Micrococcus luteus encodes an essential secreted growth factor. Mol. Microbiol. 46:611-621. (Pubitemid 35365598)
32. Mustafa AS. 1996. Recombinant mycobacterial antigens/epitopes recognized by human T-cells, p 201-211. In Mustafa AS, Al-Attiyah R, Nath I, Chugh TD (ed), T-cell subsets and cytokines interplay in infectious diseases. Karger, Basel, Switzerland.
33. Mustafa AS. 2002. Development of new vaccines and diagnostic reagents against tuberculosis. Mol. Immunol. 39:113-119. (Pubitemid 35245389)
34. Mustafa AS, Al-Saidi F, El-Shamy AS, Al-Attiyah R. 2011. Cytokines in response to proteins predicted in genomic regions of difference of Mycobacterium tuberculosis. Microbiol. Immunol. 55:267-278.
35. Nemeth J, et al. 2011. Specific cytokine patterns of pulmonary tuberculosis in Central Africa. Clin. Immunol. 138:50-59.
36. Ottenhoff THM, Kaufmann SHE. 2012. Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog. 8:e1002607. doi:10.1371/journal. ppat.1002607.
37. Ravn P, et al. 1999. Human T-cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J. Infect. Dis. 179:637-645. (Pubitemid 30016147)
38. Romano M, et al. 2012. Potential of Mycobacterium tuberculosis resuscitation-promoting factors as antigens in novel tuberculosis sub-unit vaccines. Microbes Infect. 14:86-95.
39. Roupie V, et al. 2007. Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice. Infect. Immun. 75:941-949. (Pubitemid 46203459)
40. Sable SB, Verma I, Behera D, Khuller GK. 2005. Human immune recognition-based multicomponent subunit vaccines against tuberculosis. Eur. Respir. J. 25:902-910. (Pubitemid 40667691)
41. Sable SB, Kalra M, Verma I, Khuller GK. 2007. Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity. Clin. Immunol. 122:239-251. (Pubitemid 46216915)
42. Schindler R, et al. 1990. Correlation and interactions in the production of IL-6, IL-1 and TNF in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 75:40-47. (Pubitemid 20031487)
43. Schoel B, Gulle H, Kaufmann SHE. 1992. Heterogeneity of the repertoire of T cells of tuberculosis patients and healthy contacts of Mycobacterium tuberculosis antigens separated by high-resolution techniques. Infect. Immun. 60:1717-1720.
44. Schuck SD, et al. 2009. Identification of T-cell antigens specific for latent Mycobacterium tuberculosis infection. PLoS One 4:e5590. doi:10.1371/journal.pone.0005590.
45. Sherman DR, et al. 2001. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha-crystallin. Proc. Natl. Acad. Sci. U. S. A. 98:7534-7539. (Pubitemid 32567983)
46. Talaat AM, et al. 2007. Mycobacterial bacilli are metabolically active during chronic tuberculosis in murine lungs: insights from genome-wide transcriptional profiling. J. Bacteriol. 189:4265-4274. (Pubitemid 46847375)
47. Tsenova L, et al. 2007. BCG vaccination confers poor protection against M. tuberculosis HN878-induced central nervous system disease. Vaccine 25:5126-5132. (Pubitemid 46907374)
48. Van Crevel R, Ottenhoff T, van der Meer J. 2002. Innate immunity to M. tuberculosis. Clin. Microbiol. Rev. 15:294-309.
49. Weire RE, Morgan AR, Britton WJ, Butlin CR, Dockrell HM. 1994. Development of a WB assay to measure T cell responses to leprosy: a new tool for immuno-epidemiological field studies of leprosy immunity. J. Immunol. Methods 176:93-101. (Pubitemid 24348803)
50. WHO. 2010. Global tuberculosis control 2010. WHO, Geneva, Switzerland.
51. Winek J, et al. 2008. Interferon gamma production in the course of Mycobacterium infection. J. Physiol. Pharmacol. 59(Suppl. 6):751-775.
52. Yeremeev VV, et al. 2003. Proteins of the Rpf family: immune cell reactivity and vaccination efficacy against tuberculosis in mice. Infect. Immun. 71:4789-4794. (Pubitemid 36919949)
53. Zvi A, Arie N, Fulkerson J, Sadoff JC, Shafferman A. 2008. Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses. BMC Med. Genomics 1:18.